Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001209191-16-112923

SVP, General Counsel, Sec. sold 1,556 shares at $9.41 ($14,642)

From the SEC's structured data for this filing

Trades in this filing

Hadas Nicole R. · SVP, General Counsel, Sec.

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-04-04 Sale : show line 1 in the form −1,556 $9.41 $14,642 85,528 D
Open-market sales · 1,556 sh · avg $9.41 · $14,642
Loading xslF345X03/doc4.xml…